EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients

Cancers - Switzerland
doi 10.3390/cancers9090118
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

MDPI AG

Related search

ALK in Neuroblastoma: Biological and Therapeutic Implications

Cancers
Cancer ResearchOncology
2018English

Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2010English

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

P2.13-06 TP53 Status in Relation to Response to Anti-Alk Agents in Patients With EML4-ALK-Translocated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.13-03 Real-Life Experience With Brigatinib in Pretreated EML4-ALK Translocated NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

PLoS ONE
Multidisciplinary
2014English

P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Identification of Circulating Tumor Cells With EML4‑ALK Translocation Using Fluorescence In�situ Hybridization in Advanced ALK‑positive Patients With Lung Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy